- PLN156.25m
- PLN135.49m
- PLN6.02m
Brief: Oncoarendi Therapeutics Project Qualifies For Subsidy Of About 22 Mln Zlotys From Poland's NCBiR
Brief: Oncoarendi Therapeutics Gets 22.4 Mln Zloty Subsidy From NCBR For Development Of OATD-01 Drug Candidate
Brief: Oncoarendi Therapeutics Q3 Net Loss Widens To 0.9 Mln Zlotys
Brief: Oncoarendi Therapeutics H1 Net Loss Widens To 2.0 Mln Zlotys
Brief: Oncoarendi Therapeutics FY Net Loss Widens To 4.4 Mln Zlotys
Brief: Play And Dino To Replace Energa And Eurocash In WIG20 - WSE
Brief: Oncoarendi Therapeutics 9-Month Net Loss Widens To 2.6 Mln Zlotys
Brief: Oncoarendi Therapeutics H1 Net Loss Widens To 1.9 Million Zlotys
Brief: Oncoarendi Therapeutics Q1 Net Loss Widens To 0.6 Mln Zlotys
Brief: Oncoarendi Therapeutics Consolidated FY Net Loss Flat At 2.4 Mln Zlotys
Brief: Stake Of IPOPEMA Funds In OncoArendi Lowers To 30.25%